Report Detail

Pharma & Healthcare Global Erythropoietin Drugs Market Professional Survey Report 2019

  • RnM3768271
  • |
  • 20 September, 2019
  • |
  • Global
  • |
  • 109 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule.
The retail pharmacies segment dominated the erythropoietin drugs market and accounted for a major part of the overall market share. The ability of retail pharmacies to provide a large customer base for biosimilars coupled with the requirement from anemic patients for EPO drugs as a maintenance therapy is the key contributor to the dominance of this segment in the global market.

The global Erythropoietin Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Erythropoietin Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erythropoietin Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Erythropoietin Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Erythropoietin Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others

Segment by Application
Anemia
Kidney Disorders
Other


Table of Contents

    Executive Summary

      1 Industry Overview of Erythropoietin Drugs

      • 1.1 Definition of Erythropoietin Drugs
      • 1.2 Erythropoietin Drugs Segment by Type
        • 1.2.1 Global Erythropoietin Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Epoetin-alfa
        • 1.2.3 Darbepoetin-alfa
        • 1.2.4 Epoetin-beta
        • 1.2.5 Others
      • 1.3 Erythropoietin Drugs Segment by Applications
        • 1.3.1 Global Erythropoietin Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Anemia
        • 1.3.3 Kidney Disorders
        • 1.3.4 Other
      • 1.4 Global Erythropoietin Drugs Overall Market
        • 1.4.1 Global Erythropoietin Drugs Revenue (2014-2025)
        • 1.4.2 Global Erythropoietin Drugs Production (2014-2025)
        • 1.4.3 North America Erythropoietin Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Erythropoietin Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Erythropoietin Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Erythropoietin Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Erythropoietin Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Erythropoietin Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Erythropoietin Drugs
      • 2.3 Manufacturing Process Analysis of Erythropoietin Drugs
      • 2.4 Industry Chain Structure of Erythropoietin Drugs

      3 Development and Manufacturing Plants Analysis of Erythropoietin Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Erythropoietin Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Erythropoietin Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Erythropoietin Drugs Production and Capacity Analysis
      • 4.2 Erythropoietin Drugs Revenue Analysis
      • 4.3 Erythropoietin Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Erythropoietin Drugs Regional Market Analysis

      • 5.1 Erythropoietin Drugs Production by Regions
        • 5.1.1 Global Erythropoietin Drugs Production by Regions
        • 5.1.2 Global Erythropoietin Drugs Revenue by Regions
      • 5.2 Erythropoietin Drugs Consumption by Regions
      • 5.3 North America Erythropoietin Drugs Market Analysis
        • 5.3.1 North America Erythropoietin Drugs Production
        • 5.3.2 North America Erythropoietin Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Erythropoietin Drugs Import and Export
      • 5.4 Europe Erythropoietin Drugs Market Analysis
        • 5.4.1 Europe Erythropoietin Drugs Production
        • 5.4.2 Europe Erythropoietin Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Erythropoietin Drugs Import and Export
      • 5.5 China Erythropoietin Drugs Market Analysis
        • 5.5.1 China Erythropoietin Drugs Production
        • 5.5.2 China Erythropoietin Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Erythropoietin Drugs Import and Export
      • 5.6 Japan Erythropoietin Drugs Market Analysis
        • 5.6.1 Japan Erythropoietin Drugs Production
        • 5.6.2 Japan Erythropoietin Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Erythropoietin Drugs Import and Export
      • 5.7 Southeast Asia Erythropoietin Drugs Market Analysis
        • 5.7.1 Southeast Asia Erythropoietin Drugs Production
        • 5.7.2 Southeast Asia Erythropoietin Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Erythropoietin Drugs Import and Export
      • 5.8 India Erythropoietin Drugs Market Analysis
        • 5.8.1 India Erythropoietin Drugs Production
        • 5.8.2 India Erythropoietin Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Erythropoietin Drugs Import and Export

      6 Erythropoietin Drugs Segment Market Analysis (by Type)

      • 6.1 Global Erythropoietin Drugs Production by Type
      • 6.2 Global Erythropoietin Drugs Revenue by Type
      • 6.3 Erythropoietin Drugs Price by Type

      7 Erythropoietin Drugs Segment Market Analysis (by Application)

      • 7.1 Global Erythropoietin Drugs Consumption by Application
      • 7.2 Global Erythropoietin Drugs Consumption Market Share by Application (2014-2019)

      8 Erythropoietin Drugs Major Manufacturers Analysis

      • 8.1 Amgen
        • 8.1.1 Amgen Erythropoietin Drugs Production Sites and Area Served
        • 8.1.2 Amgen Product Introduction, Application and Specification
        • 8.1.3 Amgen Erythropoietin Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Johnson & Johnson
        • 8.2.1 Johnson & Johnson Erythropoietin Drugs Production Sites and Area Served
        • 8.2.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.2.3 Johnson & Johnson Erythropoietin Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Roche
        • 8.3.1 Roche Erythropoietin Drugs Production Sites and Area Served
        • 8.3.2 Roche Product Introduction, Application and Specification
        • 8.3.3 Roche Erythropoietin Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Galenica
        • 8.4.1 Galenica Erythropoietin Drugs Production Sites and Area Served
        • 8.4.2 Galenica Product Introduction, Application and Specification
        • 8.4.3 Galenica Erythropoietin Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Emcure
        • 8.5.1 Emcure Erythropoietin Drugs Production Sites and Area Served
        • 8.5.2 Emcure Product Introduction, Application and Specification
        • 8.5.3 Emcure Erythropoietin Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Kyowa Hakko Kirin
        • 8.6.1 Kyowa Hakko Kirin Erythropoietin Drugs Production Sites and Area Served
        • 8.6.2 Kyowa Hakko Kirin Product Introduction, Application and Specification
        • 8.6.3 Kyowa Hakko Kirin Erythropoietin Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 3SBio
        • 8.7.1 3SBio Erythropoietin Drugs Production Sites and Area Served
        • 8.7.2 3SBio Product Introduction, Application and Specification
        • 8.7.3 3SBio Erythropoietin Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Biocon
        • 8.8.1 Biocon Erythropoietin Drugs Production Sites and Area Served
        • 8.8.2 Biocon Product Introduction, Application and Specification
        • 8.8.3 Biocon Erythropoietin Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 LG Life Sciences
        • 8.9.1 LG Life Sciences Erythropoietin Drugs Production Sites and Area Served
        • 8.9.2 LG Life Sciences Product Introduction, Application and Specification
        • 8.9.3 LG Life Sciences Erythropoietin Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served

      9 Development Trend of Analysis of Erythropoietin Drugs Market

      • 9.1 Global Erythropoietin Drugs Market Trend Analysis
        • 9.1.1 Global Erythropoietin Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Erythropoietin Drugs Regional Market Trend
        • 9.2.1 North America Erythropoietin Drugs Forecast 2019-2025
        • 9.2.2 Europe Erythropoietin Drugs Forecast 2019-2025
        • 9.2.3 China Erythropoietin Drugs Forecast 2019-2025
        • 9.2.4 Japan Erythropoietin Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Erythropoietin Drugs Forecast 2019-2025
        • 9.2.6 India Erythropoietin Drugs Forecast 2019-2025
      • 9.3 Erythropoietin Drugs Market Trend (Product Type)
      • 9.4 Erythropoietin Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Erythropoietin Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Erythropoietin Drugs. Industry analysis & Market Report on Erythropoietin Drugs is a syndicated market report, published as Global Erythropoietin Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Erythropoietin Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,751.00
        4,126.50
        5,502.00
        3,227.00
        4,840.50
        6,454.00
        550,165.00
        825,247.50
        1,100,330.00
        292,005.00
        438,007.50
        584,010.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report